Thank you for joining us at the AACR 2025 Annual Meeting. This year’s program included numerous scientific posters and presentations outlining the latest data, insights, and tools driving innovation in cancer research with our extensive biospecimen collection and advanced specialty lab services.
Discovery experts and strategic partners presented cutting-edge insights, highlighting collaborative efforts to accelerate breakthroughs in the field. Watch the flash talks below.
Shaping the Future of Biomarker Development with Spatial Proteomics on COMET™
Lily Reed
Sr. Technical Sales Specialist
Lunaphore
Do More With Less: Optimized Genomics Workflows Working with Limited Clinical Specimens
Tom Halsey, Ph.D.
EVP Genomics
Discovery Life Sciences
Retrospective Biomarker Testing of a Comprehensive Biorepository to Inform Complex Cohort Development
Shawn Fahl PhD
VP Lab Operations, Cell Services & R&D, Biospecimens
Discovery Life Sciences
An Overview of DiscoverAI and PathExplore
Bahar Rahsepar, Ph.D.
Associate Director of AI Products
PathAI
3D Patient-Derived Tumoroids for Compound and Immune Cell Cytotoxicity Testing
Colin Paul, PhD
R&D Staff Scientist
Thermo Fisher Scientific
TruSight™ Oncology 500 Portfolio – Enabling Comprehensive Genomic Profiling from Liquid and Tissue Biopsy
Pierre Del Moral, Ph.D., MBA
Director Clinical Marketing
Illumina
Xenium: Mapping Spatial Gene Expression with Subcellular Precision
Samantha Shelton, Ph.D.
Science & Technology Advisor
10x Genomics
Expanding the cancer biomarker landscape across plasma and FFPE matrices utilizing Olink® and mass spectrometry proteomics
Dragana Noe, Ph.D.
Director of Business Development, Mass Spectrometry and Proteomics
Discovery Life Sciences
Biospecimen Breakthroughs: Powering Precision Medicine at Scale with DNAnexus and Discovery Life Sciences
Manbir Sandhu, Ph.D.,
Senior Solutions Engineer
DNAnexus
Unlocking Transcriptomic Insights: High-sensitivity RNA-seq for Oncology Research Applications
Caitlin Gilley
Product Manager
Watchmaker Genomics
Olink® Reveal expands monitoring of the drug responses in cancer patients
Marijana Rucevic, PhD
Sr Director, Scientific Affairs
Olink
Copyright © 2025 Discovery Life Sciences. All rights reserved.
